Quantbot Technologies’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$362K Buy
+26,976
New +$402K 0.01% 1130

Other funds holding CTNM

Quantbot Technologies's CTNM Position: Q3 2026 in Review

Quantbot Technologies opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 26,976 shares worth $362K. The stake represents 0.01% of the portfolio and ranks #1130 among its holdings.

118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • Quantbot Technologies held 26,976 shares of Contineum Therapeutics worth $362K as of Q3 2026.
  • Contineum Therapeutics was a new Quantbot Technologies position in Q3 2026.
  • Contineum Therapeutics made up 0.01% of Quantbot Technologies's portfolio in Q3 2026, its #1130 holding.
  • 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on Quantbot Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.